MCL1 and neoplasm: Concerning the problem of improving the assessment of the anti-tumor activity of MCL-1 inhibitors, it is particularly interesting a recent study by Brennan and coworkers reporting the development of a humanized MCL-1 mouse strain in which murine MCL-1 was replaced with the human homolog [121].